Literature DB >> 12831875

Orexin-A (hypocretin-1) impairs Morris water maze performance and CA1-Schaffer collateral long-term potentiation in rats.

S Aou1, X-L Li, A-J Li, Y Oomura, T Shiraishi, K Sasaki, T Imamura, M J Wayner.   

Abstract

Glucose-sensitive neurons in the lateral hypothalamic area produce orexin-A (hypocretin-1) and orexin-B (hypocretin-2) and send their axons to the hippocampus, which predominantly expresses orexin receptor 1 showing a higher sensitivity to orexin-A. The purpose of the present study was to assess the effects of orexin-A on the performance of Wistar rats during the Morris water maze test and then to determine the effects of orexin-A on both the long-term potentiation and long-term depression in Schaffer collateral/commissural-CA1 synapses in hippocampal slices. The results of the Morris water maze test show that 1.0 and 10 nmol of orexin-A, when administered intracerebroventricularly, retarded spatial learning. A probe test examined after training of water maze task also showed an impairment in spatial memory. The results of an electrophysiological study using hippocampal slices demonstrated that 1.0 to 30 nM of orexin-A applied to the perfusate produces a dose-dependent and time dependent suppression of the long-term potentiation. In addition, the long-term depression was not affected by orexin-A. The results of a paired-pulse facilitation experiment indicated that the effects of orexin-A were post-synaptic and not due to presynaptic transmitter release. These results show that orexin-A impairs spatial performance and these impairments can be attributed to a suppression of long-term potentiation in the Schaffer collateral-CA1 hippocampal synapses.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12831875     DOI: 10.1016/s0306-4522(02)00745-5

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  16 in total

1.  Antagonism of orexin 1 receptors eliminates motor hyperactivity and improves homing response acquisition in juvenile rats exposed to alcohol during early postnatal period.

Authors:  Georg M Stettner; Leszek Kubin; Denys V Volgin
Journal:  Behav Brain Res       Date:  2011-03-21       Impact factor: 3.332

Review 2.  K+ channels stimulated by glucose: a new energy-sensing pathway.

Authors:  Denis Burdakov
Journal:  Pflugers Arch       Date:  2007-01-06       Impact factor: 3.657

Review 3.  The hypocretins/orexins: integrators of multiple physiological functions.

Authors:  Jingcheng Li; Zhian Hu; Luis de Lecea
Journal:  Br J Pharmacol       Date:  2014-01       Impact factor: 8.739

4.  Hypocretin/orexin knock-out mice display disrupted behavioral and dopamine responses to cocaine.

Authors:  Jessica K Shaw; Mark J Ferris; Jason L Locke; Zachary D Brodnik; Sara R Jones; Rodrigo A España
Journal:  Addict Biol       Date:  2016-08-02       Impact factor: 4.280

Review 5.  The hypocretin/orexin system as a target for excessive motivation in alcohol use disorders.

Authors:  David E Moorman
Journal:  Psychopharmacology (Berl)       Date:  2018-03-06       Impact factor: 4.530

6.  Diurnal inhibition of NMDA-EPSCs at rat hippocampal mossy fibre synapses through orexin-2 receptors.

Authors:  Martina Perin; Fabio Longordo; Christine Massonnet; Egbert Welker; Anita Lüthi
Journal:  J Physiol       Date:  2014-08-01       Impact factor: 5.182

7.  Orexin/hypocretin receptor 1 signaling mediates Pavlovian cue-food conditioning and extinction.

Authors:  Sara E Keefer; Sindy Cole; Gorica D Petrovich
Journal:  Physiol Behav       Date:  2016-03-02

8.  Orexin A-induced enhancement of attentional processing in rats: role of basal forebrain neurons.

Authors:  Kristin N Zajo; Jim R Fadel; Joshua A Burk
Journal:  Psychopharmacology (Berl)       Date:  2015-11-04       Impact factor: 4.530

9.  Orexin-A aggravates cytotoxicity and mitochondrial impairment in SH-SY5Y cells transfected with APPswe via p38 MAPK pathway.

Authors:  Maoyu Li; Yao Meng; Bingcong Chu; Yang Shen; Xiangtian Liu; Mao Ding; Chaoyuan Song; Xi Cao; Ping Wang; Linlin Xu; Yun Wang; Shunliang Xu; Jianzhong Bi; Zhaohong Xie
Journal:  Ann Transl Med       Date:  2020-01

Review 10.  Intranasal insulin and orexins to treat age-related cognitive decline.

Authors:  Jennifer M Erichsen; Coleman B Calva; Lawrence P Reagan; Jim R Fadel
Journal:  Physiol Behav       Date:  2021-02-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.